| Facial Procedures | Laser Treatments | About Us | Contact Us | Photo Gallery |
NEW York OFFICE
|
Dr. Gervais FrÉchette
PATIENTS TRAVEL FROM ALL OVER NORTH AMERICAN TO SEE DR. FRÉCHETTE
Although Sculptra® was unanimously approved by the FDA on August 3, 2004, Dr. Fréchette continues his dedication to correcting facial wasting as the Principal Investigator on a long term research study of Sculptra®. Additionally, Dermik has hired Dr. Fréchette to train other HIV Specialists, physicians, dermatologists and plastic surgeons on his time proven artistic technique for the administration of Sculptra®. Patients fly from all over North America to see Dr. Fréchette for their Sculptra® needs. To better serve the HIV community and a growing patient load, in 2004 Dr. Fréchette became licensed in California and opened a secondary practice in San Francisco. Dr. Fréchette is not only THE Doctor who fought for the Sculptra® Assistance Program, he is also THE Doctor other physicians come to for Sculptra® treatments. Dr. Fréchette decided early in his practice that he never wanted to compromise a medical decision based on the business restrictions of a third party. His goal has always been to deliver the highest quality of care to all his patients, making decisions entirely independent of managed care agreements. |
Dr. Gervais Fréchette obtained his Doctorate in Medicine from the University of Montreal, School of Medicine in 1986 where he graduated at the top of his class. He completed his post-graduate at St-Luc’s Hospital in Montreal and obtained his license to practice medicine in 1987. In 1996 Dr. Fréchette moved to New York City where he has continued to dedicate his work to helping people living with HIV. Dr. Fréchette has concentrated his practice on HIV/AIDS for 20 years and is a Certified HIV Specialist by the American Academy of HIV Medicine.
In 2001 Dr. Fréchette traveled to Paris where he was extensively trained with an injectable facial filler called New-Fill which is now distributed by Sanofi/Aventis/Dermik under the trade name Sculptra®. Dr. Fréchette received comprehensive training from Dr. LaGlenne, the developer of New-Fill/Sculptra® in both the reconstructive as well as cosmetic applications for the product. Dr. Fréchette has performed several thousands successful Sculptra® procedures with outstanding results and is regarded as the industry leader. His pioneering work with Sculptra® from 2001 until his testimony before the FDA on March 24th, 2004 was critical for Sculptra®’s approval.